Sign in for the best experience.
Explore new and notable updates in pulmonary vascular disease, including research into best practices for evaluating for pulmonary embolism (PE) in pregnant patients, off-label dosing of direct oral anticoagulants in cardiopulmonary disease, and management of post-COVID-19 pulmonary disease. Read the latest from Networks members in the CHEST Physician® publication, access comprehensive resources to help patients understand their pulmonary arterial hypertension (PAH) diagnosis, and more.
Comparison of Guidelines for Evaluation of Suspected Pulmonary Embolism in Pregnancy: A Cost-effectiveness Analysis
The Right Heart Network and Risk Stratification in Pulmonary Arterial Hypertension
The Right Ventricular-Pulmonary Arterial Coupling and Diastolic Function Response to Therapy in Pulmonary Arterial Hypertension
Off-Label Use and Inappropriate Dosing of Direct Oral Anticoagulants in Cardiopulmonary Disease
Novel Mechanisms Targeted by Drug Trials in Pulmonary Arterial Hypertension
Should therapeutic heparin be administered to acutely-ill hospitalized patients with COVID-19 David Jimenez, MD, PhD, FCCP; Tobias Tritschler, MD, MSc; and Gretchen Winter, MD (moderator)
This visual abstract compares the efficacy and safety of rivaroxaban versus dalteparin for the treatment of cancer-associated thromboembolism by measuring the cumulative incidence of recurrent venous thromboembolism and worsening of obstruction after 3 months.
VIEW THE DOWNLOADABLE JPEG
CHEST Journal | Access even more pulmonary vascular disease research. READ THE JOURNAL »
Pros & cons of PE management
PAH Myths Busted
VTE prophylaxis in critical illness
Simulation courses
Advertisement
Some aspects of treatment for acute pulmonary embolism remain controversial. Review pros and cons of each in this course.
Review the latest update to CHEST’s guidelines for antithrombotic therapy and the prevention of thrombosis.
Practice your sleuthing skills by reviewing “evidence” for each patient to deduce the appropriate diagnosis and treatment strategy.
A new diagnosis of PAH can be confusing and frightening for patients. Help them better understand their disease and what to expect from treatment with resources covering the symptoms, therapies, and risk factors for PAH and busting common myths surrounding living with this disease. Plus, a comprehensive patient guide offers an in-depth look into every aspect of PAH, from diagnosis to treatment and long-term management.
DOWNLOADPAH MYTHS BUSTED
DOWNLOADPAH INFOGRAPHIC
DOWNLOADNAVIGATING PAH: PATIENT EDUCATION GUIDE
Venous Thromboembolism Prophylaxis in Critically Ill Adults
Explore the latest data on preventing venous thromboembolism in critically ill adults, including considerations for generalizing prophylaxis measures across ICU patients.
Among critically ill adults, low-molecular-weight heparin reduces deep vein thrombosis
Read a summary of findings from a study comparing the efficacy of various treatment strategies for the treatment of thrombosis, including heparin.
When Is It Not PAH?
Review how to distinguish between patients with PAH and those with heart or lung disease that presents similarly to PAH.
Targeted temperature management (TTM) after cardiac arrest: How cool?
Enhance your understanding of targeted temperature management in this review from Section Member-at-Large, Fiore Mastroianni, MD.
Withholding anticoagulation for isolated subsegmental pulmonary embolism – Houston, we have a problem
Aaron Holley, MD, FCCP, debates recent guidance regarding withholding anticoagulation for some patients with pulmonary embolism.
COVID Beyond the ICU: Management of Post-COVID-19 Pulmonary Disease
Review the signs and symptoms of post-COVID-19 pulmonary disease, tools for evaluation, and emerging data on management strategies.
Improve your skills in point-of-care ultrasound, and develop a systematized method for approaching whole-body ultrasound.
November 10-11, 2022
Review all aspects of the management of intermediate- and high-risk pulmonary embolism (PE) with three PE experts.
1.25 AMA PRA Category 1 Credits™
Stay up-to-date on the dramatic evolutions in pulmonary embolism care, including changes to risk stratification and advancements in reperfusion strategies.
If you’re not already a CHEST member, become one today for access to additional resources, discounts on educational activities, and networking opportunities.
JOIN NOW »